DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea
· Delayed Price · Currency is KRW 15,980
+120 (0.76%)
Feb 21, 2025, 3:30 PM KST
DongKook Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 702,614 | 710,431 | 729,658 | 958,073 | 1,285,488 | 783,159 | Upgrade
|
| Market Cap Growth | 13.77% | -2.64% | -23.84% | -25.47% | 64.14% | 53.89% | Upgrade
|
| Enterprise Value | 768,617 | 751,610 | 743,265 | 932,778 | 1,201,020 | 718,740 | Upgrade
|
| Last Close Price | 15980.00 | 15966.70 | 16218.07 | 21076.18 | 28053.09 | 16986.52 | Upgrade
|
| PE Ratio | 11.59 | 15.06 | 13.79 | 19.03 | 22.99 | 13.91 | Upgrade
|
| Forward PE | 10.65 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | Upgrade
|
| PS Ratio | 0.89 | 0.97 | 1.10 | 1.61 | 2.30 | 1.62 | Upgrade
|
| PB Ratio | 1.22 | 1.18 | 1.31 | 1.90 | 2.82 | 2.03 | Upgrade
|
| P/TBV Ratio | 1.31 | 1.33 | 1.48 | 2.14 | 3.18 | 2.19 | Upgrade
|
| P/FCF Ratio | 26.91 | 93.28 | - | - | 65.92 | 17.66 | Upgrade
|
| P/OCF Ratio | 13.06 | 17.00 | 17.84 | 21.46 | 21.75 | 11.27 | Upgrade
|
| EV/Sales Ratio | 0.97 | 1.03 | 1.12 | 1.57 | 2.15 | 1.49 | Upgrade
|
| EV/EBITDA Ratio | 6.98 | 8.54 | 8.02 | 11.58 | 12.29 | 8.73 | Upgrade
|
| EV/EBIT Ratio | 9.21 | 11.24 | 10.11 | 14.75 | 14.54 | 10.46 | Upgrade
|
| EV/FCF Ratio | 29.44 | 98.69 | - | - | 61.59 | 16.21 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.13 | 0.12 | 0.19 | 0.15 | 0.16 | Upgrade
|
| Debt / EBITDA Ratio | 0.69 | 0.87 | 0.72 | 1.22 | 0.70 | 0.73 | Upgrade
|
| Debt / FCF Ratio | 2.88 | 10.07 | - | - | 3.51 | 1.36 | Upgrade
|
| Asset Turnover | 0.90 | 0.91 | 0.87 | 0.84 | 0.93 | 0.94 | Upgrade
|
| Inventory Turnover | 2.30 | 2.48 | 2.53 | 2.69 | 3.17 | 3.08 | Upgrade
|
| Quick Ratio | 1.32 | 1.34 | 1.49 | 1.40 | 2.15 | 2.47 | Upgrade
|
| Current Ratio | 2.13 | 2.06 | 2.22 | 1.91 | 2.75 | 3.08 | Upgrade
|
| Return on Equity (ROE) | 10.25% | 8.42% | 10.33% | 11.03% | 13.76% | 16.47% | Upgrade
|
| Return on Assets (ROA) | 5.94% | 5.20% | 6.05% | 5.59% | 8.55% | 8.38% | Upgrade
|
| Return on Capital (ROIC) | 7.43% | 6.41% | 7.51% | 7.02% | 10.64% | 10.32% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.92% | 10.51% | 12.36% | 11.93% | 15.94% | 15.82% | Upgrade
|
| Earnings Yield | 8.77% | 6.64% | 7.25% | 5.25% | 4.35% | 7.19% | Upgrade
|
| FCF Yield | 3.72% | 1.07% | -0.96% | -0.66% | 1.52% | 5.66% | Upgrade
|
| Dividend Yield | 1.13% | 1.13% | - | - | - | - | Upgrade
|
| Payout Ratio | 13.48% | 17.07% | 15.22% | 15.99% | 12.79% | 8.26% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.02% | -0.01% | - | - | -0.94% | Upgrade
|
| Total Shareholder Return | 1.11% | 1.11% | -0.01% | - | - | -0.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.